Abstract
Postoperative (or postpancreatectomy) acute pancreatitis (PPAP) in the pancreatic remnant has recently been recognized as a distinct complication entity that may occur after both partial pancreatoduodenectomy (PD) and distal pancreatectomy (DP). However, it remains unclear what constitutes PPAP. Moreover, the pathophysiologic events leading to PPAP are not fully understood and no internationally accepted definition of PPAP exists. Recent studies mostly used an early postoperative increase of serum amylase above the institutional upper limit of normal to diagnose PPAP, but this resulted in exceptionally high PPAP rates exceeding 50% after PD and DP in those studies. To assume that more than 50% of those patients who had undergone PD or DP develop PPAP is at least questionable or may even be exaggerated. This article summarizes the current evidence on PPAP and on the diagnostic potential of postoperative pancreatic serum enzyme levels to identify patients suffering from PPAP.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
